Phosphodiesterase 5A as a target in cardiac disease

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.9, Iss.5, 2005-10, pp. : 1097-1100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer’s Disease: A Translational Overview

Current Pharmaceutical Design, Vol. 21, Iss. 3, 2015-01 ,pp. : 317-331

Bentham Science Publishers

Access to resources Recommend Favorite

Calmodulin kinase II as a target for inhibition in cardiac disease

By Doggrell Sheila A

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. : 1319-1321

Informa Healthcare

Access to resources Recommend Favorite

Phosphodiesterase-4 as a potential drug target

By Zhang Kam YJ Ibrahim Prabha N Gillette Sam Bollag Gideon

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. : 1283-1305

Informa Healthcare

Access to resources Recommend Favorite

Sarcoplasmic reticulum and cardiac oxidative stress: an emerging target for heart disease

By Dhalla N.S. Temsah R.M.

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 2, 2001-04 ,pp. : 205-217

Informa Healthcare

Access to resources Recommend Favorite

Inhaled phosphodiesterase type 5 inhibitors for cystic fibrosis: a new therapy for systemic disease?

By Antoniu Sabina Antonela

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 5, 2011-05 ,pp. : 713-715

Informa Healthcare

Access to resources Recommend Favorite